At Kisco our top priority from the beginning of the pandemic has been to keep residents and associates as safe as possible, and we are indebted to our community teams who have worked tirelessly to achieve this objective. Our communities have conducted over 50,000 COVID-19 tests and we continue to lead the industry in efforts to minimize those affected by this horrible disease.

Residents and staff in senior living communities are included in the highest priority groups for COVID-19 vaccination and our teams are working with selected pharmacies to facilitate vaccination clinics at all Kisco communities.

Kisco COVID-19 Vaccine Statement

COVID-19 Testing Strategy

October 7, 2020 | Throughout the COVID-19 pandemic, Kisco Senior Living has kept the safety of its residents and associates its top priority. Now the senior living company is taking it one step further with an innovative approach to testing, similar to the method taken by professional sports teams. Using pooled saliva PCR testing, Kisco Senior Living is aiming to create a “safety bubble,” giving the company the confidence to open up operationally. The saliva PCR test was recently approved by the Food and Drug Administration (FDA) and will be given to all residents once a week and all associates twice a week. The company is partnering with SiREM labs for the testing and will be sending approximately 32,000 vials per month from its 20 senior living communities to the laboratory for processing.

Read More